Table 1.

Cerebrospinal fluid (CSF) study result

Parameters	Results
Opening pressure (10–18 cm of H2O)	12 cm of H2O
Color	Clear
Cells	o/mm3
Gram stain and culture	Negative
Glucose (40–70 mg/dL)	72 mg/dL
Protein (15–45 mg/dL)	60 mg/dL
VDRL test	Non-reactive
HSV 1–2 by PCR	Negative
CMV IgM	Negative
B. burgdorferi IgGM and IgG	Negative
VZV by PCR	Negative
EBV by PCR	Negative
Paraneoplastic Autoantibodies Panel
ANNA-1/anti-Hu	Negative at <1:2
ANNA-2/anti-Ri	Negative at <1:2
ANNA-3	Negative at <1:2
AGNA-1	Negative at <1:2
PCA-1/anti-Yo	Negative at <1:2
Amphiphysin Ab	Negative at <1:2
CRMP-5-IgG/anti-CV2	Negative at <1:2
PNMA-2/Ma2/Ta	Negative at <1:2
Recoverin	Negative at <1:2
SOX-1	Negative at <1:2
Titin	Negative at <1:2
Zic4	Negative at <1:2
Tr (DNER)	Negative at <1:2
GAD65	Negative at <1:2
Autoimmune Encephalitis Panel
NMDAR	Negative
AMPA-1	Negative
AMPA-2	Negative
CASPR-2	Negative
GABAR-B1/B2	Negative
LGI-1	Negative
SARS-CoV-2 (2019-nCoV RNA) PCR	Negative
Oligoclonal bands (OCBs)	Tip 2 (21 bands positive)
IgG Index (<0.77)	0.4668
IgG (0–34 mg/L)	47
Anti-ganglioside Panel
GM1, GM2, GM3	Negative
GD1a, GD1b	Negative
GT1b	Negative
GQ1b	Negative

AMPA: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; ANNA: Antineuronal nuclear antibody; CASPR2: Contactin-associated protein-like 2; CMV: Cytomegalovirus; CRMP: Collapsin response mediator protein; DNER: Delta/notch-like epidermal growth factor-related receptor; EBV: Epstein Barr Virus; GABAR: Gamma aminobutyric acid receptor; GAD65: Glutamic Acid Decarboxylase; GM: Ganglioside-monosialic acid; HSV: Herpes Simplex Virus; LGI-1: Leucine rich glioma inactivated-1; NMDAR: N-methyl D-aspartate receptor; PCA: Purkinje cell cytoplasmic antibody; PNMA: Paraneoplastic Ma antigen; VZV: Varicella Zoster Virus.